Islets of Langerhans TransplantationLangerhans CellsIslets of LangerhansLiver TransplantationTransplantation, HomologousKidney TransplantationHistiocytosis, Langerhans-CellBone Marrow TransplantationSurvival RateGraft SurvivalHematopoietic Stem Cell TransplantationHeart TransplantationTransplantation, AutologousCell SurvivalLung TransplantationStem Cell TransplantationTransplantation ConditioningGraft RejectionOrgan TransplantationPancreas TransplantationTissue DonorsTreatment OutcomeDisease-Free SurvivalSurvival AnalysisTransplantationTransplantation ImmunologyCell TransplantationTime FactorsImmunosuppressive AgentsTransplantation ChimeraRetrospective StudiesTransplantation, IsogeneicTransplantation, HeterotopicIslet Amyloid PolypeptideInsulinGraft vs Host DiseaseSurvivalEpidermisLiving DonorsCord Blood Stem Cell TransplantationImmunosuppressionHeart-Lung TransplantationInsulin-Secreting CellsMice, Inbred C57BLFollow-Up StudiesTransplantation ToleranceTissue and Organ ProcurementSkin TransplantationMannose-Binding LectinsLangerhans Cell SarcomaSkinTransplantation, HeterologousGlucoseHistocompatibility TestingLiver FailureCells, CulturedPeripheral Blood Stem Cell TransplantationPostoperative ComplicationsFetal Tissue TransplantationRecurrenceMice, Inbred BALB CCorneal TransplantationDiabetes Mellitus, Type 1ImmunohistochemistryKaplan-Meier EstimateCombined Modality TherapyCell DifferentiationWaiting ListsDermatitis, ContactAntigens, CD1TacrolimusPancreasGlucagon-Secreting CellsMesenchymal Stem Cell TransplantationPrognosisHistocompatibilityDiabetes Mellitus, ExperimentalCyclosporineCadaverT-LymphocytesHematologic NeoplasmsWhole-Body IrradiationOrgan PreservationMice, TransgenicTissue TransplantationRisk FactorsDendritic CellsApoptosisAntineoplastic Combined Chemotherapy ProtocolsAntigens, CDCell CountProportional Hazards ModelsGlucagonCell MovementInsulinomaMice, Inbred NODRats, Inbred LewDisease Models, AnimalBrain Tissue TransplantationDonor Selection